Duncan Walker
5Patents
2h-index
5Co-inventors
40Inventor score
Filing activity: Mar 14, 2005 → Jul 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7968565B2 | Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid | Emerging Cross-Sectional Technologies | 33 | Active |
| US8822493B2 | SNS-595 and methods of using the same | Emerging Cross-Sectional Technologies | 3 | Active |
| US9561214B2 | Method of treatment using inhibitors of mitosis | Human Necessities | 1 | Active |
| US11857535B2 | Methods of treating mutant lymphomas | Human Necessities | 1 | Active |
| US9980949B2 | SNS-595 and methods of using the same | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.